AZTA: Azenta Inc Price to Sales

Symbol and logo of brand Azenta Inc (AZTA)

Azenta, Inc. (AZTA) monetizes cryogenic infrastructure through software and DNA storage rentals. The company's smoothed P/S ratio on the GURU.Markets chart demonstrates the evolution of this model, where 3.10 captures the current value of the indicator. The issuer's revenues are based on orders from pharmaceutical centers and laboratory automation, while the business implements eco-design and reduces production energy costs.

AZTA (Azenta) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for Azenta Life Sciences (AZTA)

- market price and analyst price targets:
Stock Quotes azenta.com|AZTA - Analyst Consensus Forecast
- market capitalization information:
Market Value Azenta Life Sciences|AZTA - Enterprise Value
- shareholders' equity book value data:
Equity per Share Azenta|AZTA - Book Capitalization|Market Capitalization to Book Value azenta.com|AZTA - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Azenta, Inc.|AZTA - Long-Term Debt to Capital|Short-Term Debt to Capital Brooks Automation|AZTA - Company Debts|Debt to Book Capitalization Ratio Azenta Life Sciences|AZTA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Azenta|Immediate Liquidity azenta.com
- net income and valuation multiples indicators:
AZTA - Company Net Income|Projected Net Profit Azenta, Inc.|AZTA - Price to Earnings Ratio|Forward P/E Multiple Azenta Inc|AZTA - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Azenta Life Sciences|AZTA - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Azenta|AZTA - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months azenta.com|AZTA - Earnings growth in current year|Expected net earnings per share growth next year Azenta, Inc.
- issuer revenue and sales details:
AZTA - Company Revenue|Company Revenue Forecast azenta.com|AZTA - Market Cap to Revenue|Price to Expected Revenue Ratio Azenta Life Sciences
Fundamental company analysis:azenta.com AZTA
Original product of Azenta Life Sciences

When selecting defensive assets, priority is given to companies with a stable market share, which Azenta, Inc. (AZTA) possesses due to the high switching costs for clients moving to other biosample storage systems. The current P/S multiple of 3.10 reflects the market value of one dollar of revenue, allowing this chart to assess the adequacy of the business capitalization relative to its actual sales volumes.

Who Azenta, Inc. competes with

Market Cap to Revenue abbott.com ABT|P/S Multiple TMO (Thermo Fisher)|GE HealthCare Technologies Inc. (GEHC) - Price to Sales|Mettler-Toledo International Inc. - P/S Multiple|WAT (Waters Technologies) - Market Cap to Revenue Ratio|TECH: P/S Multiple|BRKR - Price-to-Revenue Coefficient|VREX (Varex Imaging Corporation) - P/S Multiple|Market Cap to Revenue Semler Scientific Inc (SMLR)|P/S Multiple BFLY|P/S Multiple Mesa Laboratories Corp. (MLAB)|Price-to-Revenue Ratio Quantum-Si QSI|nanox.vision - Price-to-Revenue Ratio|QTRX: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio MASS (908 Devices Inc)|CV: P/S Multiple|Price to Sales MaxCyte Inc (MXCT)|Price-to-Revenue Ratio Rapid Micro Biosystems Inc.|SEER - Price-to-Revenue Multiple|Market Cap to Revenue HYPR (Hyperfine)|P/S Multiple FONAR Corp. (FONR)|P/S Multiple DXR (Daxor)|Price-to-Revenue Coefficient spectral-ai.com (MDAI)|VIVS - Price-to-Revenue Ratio|Price-to-Sales Ratio ACON|akoyabio.com (AKYA) - Price-to-Revenue Ratio|Market Cap to Revenue ThermoGenesis Holdings, Inc.|TLIS (Talis Biomedical Corp.) - P/S Multiple|Price to Sales T2 Biosystems Inc TTOO